1.360USD-1.45%Mkt Cap: 457.00M USDP/E: —Last update: 2026-06-01
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product inclu…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap457.00M USD
Enterprise Value468.60M USD
Revenue (TTM)4.46M USD
Gross Profit-35.63M USD
Net Income (TTM)-67.85M USD
Revenue/Share0.0140 USD
Last Price1.360 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees116
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.87
PEG—
EV/EBITDA-7.34
EV/Revenue104.95
P/S104.63
P/B-35.38
EPS (TTM)-0.24
EPS (Forward)-0.23
52W Range
0.800029% of range2.725
52W High2.725 USD
52W Low0.8000 USD
Profitability
Gross Margin0.00%
Oper. Margin-1163.67%
EBITDA Margin0.00%
Profit Margin-1537.41%
ROE557.67%
ROA-155.91%
Growth
Revenue Growth3.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-56.96M USD
CapEx (TTM)185.00K USD
FCF Margin-753.99%
FCF Yield-7.37%
Net Debt1.44M USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity-2.72
Current Ratio1.86
Quick Ratio1.54
Book Value/Sh-0.0390 USD
Cash/Share0.0940 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 30, 2019
Splits
Last Split1:60
Split DateSep 30, 2019
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)11.43 USD
Target Range7.000 USD – 22.00 USD
# Analysts7
Ownership
Shares Out.338.52M
Float316.86M
Insiders1.68%
Institutions34.09%
Short Interest
Short Ratio10.2d
Short % Float24.07%
Short % Out.23.94%
Shares Short81.05M
Short (prev mo.)67.89M
Technical
SMA 501.700 (-20.0%)
SMA 2001.513 (-10.1%)
Beta2.31
S&P 52W Chg27.94%
Avg Vol (30d)7.31M
Avg Vol (10d)4.88M
Technical Indicators
RSI (14)39.5
MACD-0.0933
MACD Signal-0.1039
MACD Hist.+0.0105
BB Upper1.734 USD
BB Middle1.452 USD
BB Lower1.170 USD
BB Width38.88%
ATR (14)0.0912 USD
Vol Ratio (20d)1.52x